HAEMONETICS CORP. overview

Haemonetics Announces Executive Leadership Updates PR Newswire BOSTON, March 3, 2025 Frank Chan joins Haemonetics as Executive Vice President, Chief Operating Officer; Roy Galvin named Executive Vice President, Chief Commercial Officer BOSTON , March 3, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced updates to its Executive Leadership team. Frank...

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference PR Newswire BOSTON, Feb. 24, 2025 BOSTON , Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET . The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations...

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire BOSTON, Feb. 6, 2025 Financial release accessible online BOSTON , Feb. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024 , are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer...

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A PR Newswire BOSTON, Jan. 14, 2025 BOSTON , Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has completed the previously announced sale of its whole blood assets to GVS, S.p.A ("GVS"), one of the world's leading manufacturers of filter solutions for applications in the...

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 PR Newswire BOSTON, Jan. 8, 2025 BOSTON , Jan. 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025 . The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025 . The call can...

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 6, 2025 BOSTON , Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time . The public may access Mr. Simon's presentation live via audio webcast at:...

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A PR Newswire BOSTON, Dec. 3, 2024 BOSTON , Dec. 3, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, S.p.A ("GVS"), one of the world's leading manufacturers of filter solutions for applications in the...

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire BOSTON, Nov. 7, 2024 Financial release accessible online BOSTON , Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024 , are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer...